| Literature DB >> 9326356 |
P Massaro1, P Foa, M Pomati, M L LaTargia, A Iurlo, C Clerici, S Caldiera, M Fornier, A T Maiolo.
Abstract
We periodically analyzed bone-marrow cytogenetic features in 8 patients belonging to a series of 38 subjects with polycythemia vera (PV), all treated with recombinant interferon-alpha 2a (rIFN-alpha) at a weekly dose of 9,000,000 IU. Six out of these 8 patients never showed any chromosome alterations, while 2 displayed at diagnosis the presence of trisomy 8 in all bone-marrow metaphases. Interestingly enough, in these 2 patients rIFN-alpha treatment was able to induce not only complete hematological response but also the disappearance of trisomy 8, as shown by conventional cytogenetic investigation and fluorescence in situ hybridization performed on bone-marrow cells after 1 year of treatment. This finding indicates that, as previously shown in chronic myeloid leukemia, in PV rIFN-alpha can also eradicate the malignant clone by means of a selective effect on bone-marrow transformed cells.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9326356 DOI： 10.1002/(sici)1096-8652(199710)56:2<126::aid-ajh10>3.0.co;2-a
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047